Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Genentech Inc
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
Clinical study of MCMV5322A/MCMV3068A in kidney transplant recipients at high risk for CMV disease
•To evaluate the safety of multiple IV doses of MCMV5322A/MCMV3068A given to cytomegalovirus (CMV) seronegative recipients of a renal transplant from a CMV seropositive donor. •To determine the clin...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY REGIMENS IN SUBJECTS WITH PREVIOUSLY TREATED METASTATIC BREAST CANCER
The primary objective of the study is to determine the clinical benefit of the addition of bevacizumab to standard chemotherapy for previously treated MBC in subjects without brain metastasis as measu...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A randomized phase II study assessing the safety and efficacy of ipatasertib in patients with breast cancer that has spread beyond the initial site, without certain hormonal receptors
To estimate the efficacy of ipatasertib combined with paclitaxel compared with placebo combined with paclitaxel in patients with inoperable locally advanced or metastatic triple negative breast cancer...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVENOUS MEMP1972A IN THE PREVENTION OF ALLERGEN-INDUCED AIRWAY OBSTRUCTION IN PATIENTS WITH MILD ASTHMA
The primary objective of this study is to evaluate whether MEMP1972A decreases the allergen-induced late airway response (LAR) after 12 weeks of exposure.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
Treatment of Adult Allergic Asthma Patients with MEMP1972A
The primary objectives of this study are to evaluate the efficacy and safety of MEMP1972A in adult patients with allergic asthma inadequately controlled despite high dose inhaled corticosteroids ( ICS...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A Randomized Phase II Study of GDC-0068, an Inhibitor to Akt, in Combination with Fluoropyrimidine Plus Oxaliplatin Chemotherapy (mFOLFOX6) in Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer. ESTUDIO ALEATORIZADO, EN FASE II, CON GDC 0068, UN INHIBIDOR DE AKT, EN COMBINACIÓN CON UNA FLUOROPIRIMIDINA MÁS QUIMIOTERAPIA DE OXALIPLATINO (mFOLFOX6) EN PACIENTES CON CANCER LOCALMENTE AVANZADO O GASTRICO METASTÁSICO DE LA UNIÓN GASTROESOFÁGICA
To estimate the efficacy of GDC-0068 combined with mFOLFOX6 chemotherapy compared with placebo combined with mFOLFOX6 chemotherapy in patients with inoperable locally advanced or metastatic gastric or...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults Un estudio de MHAA4549A como monoterapia para gripe A estacional aguda no complicada en adultos sanos
To evaluate the safety and tolerability of a single IV dose of MHAA4549A as compared to placebo when administered in otherwise healthy patients with acute uncomplicated seasonal influenza A, focusing ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
A Study of Patients Previously Enrolled in Study GA29350 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients with Moderate to Severe Rheumatoid Arthritis
• To evaluate the long-term safety of GDC-0853 over an extended treatment period of up to 52 weeks • To evaluate the efficacy of GDC-0853 (analysed separately for methotrexate-inadequate response [MTX...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
An evaluation of the investigational drug GDC-0980 in patients with metastatic kidney cancer who have already received up to three therapies, with the approved drug everolimus as a comparison
•To evaluate the efficacy of GDC-0980 versus everolimus as measured by progression-free survival (PFS) defined as the time from randomization to disease progression
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Genentech Inc
MAJ Il y a 4 ans
Marker Evaluation for Avastin Research in colorectal cancer
To assess whether: • Expression of chemotherapy resistance marker ERCC-1 is associated with progression-free survival (PFS) in first-line metastatic colorectal cancer (CRC) patients treated with beva...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
Suivant